Drug Insights

Optimize Your Synapse Experience: A Step-by-Step Guide to Searching Fluticasone Propionate

24 March 2024
2 min read

Fluticasone Propionate, a small molecule drug, targets the glucocorticoid receptor and acts as an agonist. The drug has been approved for the treatment of various dermatological conditions such as dermatitis, contact dermatitis, seborrheic dermatitis, eczema, erythema, lichen planus, and discoid lupus erythematosus, among others. Additionally, it has been approved for the treatment of nasal polyps, neurodermatitis, and prurigo. However, the drug's mechanism of action remains unknown. GSK is the originator organization of fluticasone propionate, and it was first approved for use in December 1990. Fluticasone propionate has potent anti-inflammatory and immunosuppressive effects due to the activation of the glucocorticoid receptor, which make it effective in treating the symptoms associated with these conditions. Nevertheless, like all medications, fluticasone propionate has potential side effects such as adrenal suppression, increased risk of infections, and osteoporosis, among others, and should be used under the guidance of a healthcare provider. Click on the image below to begin the exploration journey of Fluticasone Propionate through the Synapse database!

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

CheckMate -9DW Success: Opdivo and Yervoy Boost Survival in Progressive Liver Cancer
Latest Hotspot
3 min read
CheckMate -9DW Success: Opdivo and Yervoy Boost Survival in Progressive Liver Cancer
22 March 2024
Bristol Myers Squibb Reveals Successful Outcome for CheckMate -9DW Study Assessing the Combination of Opdivo and Yervoy in Extending Survival in Initial Therapy of Progressive Liver Cancer.
Read →
What is the meaning of over-the-counter(OTC) drugs?
"What" Series
2 min read
What is the meaning of over-the-counter(OTC) drugs?
22 March 2024
Over-the-counter (OTC) drugs are medications that can be purchased and used without a prescription from a healthcare provider.
Read →
FDA Approves Idorsia's TRYVIO, First Endothelin Antagonist for Resistant Hypertension
Latest Hotspot
3 min read
FDA Approves Idorsia's TRYVIO, First Endothelin Antagonist for Resistant Hypertension
22 March 2024
The FDA has approved Idorsia's daily drug TRYVIO (aprocitentan), the first to use an endothelin receptor antagonist for managing resistant hypertension alongside other medications.
Read →
The Synapse User's Toolkit: Tips for Searching Propofol
Drug Insights
2 min read
The Synapse User's Toolkit: Tips for Searching Propofol
22 March 2024
Propofol, an agonist of the GABAA receptor, is a small molecule drug primarily used for anesthesia.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.